OrthAlign, a private medical device company, has secured FDA 510(k) clearance for its Lantern Hip handheld technology, specifically designed for direct anterior total hip arthroplasty (THA) with the patient in a supine position.

This latest innovation expands the Lantern platform, which already includes applications for total knee, revision knee, and partial knee replacements.

Building on the foundation of its predecessor, HipAlign®, the Lantern Hip incorporates advanced technology, offering surgeons an improved workflow and real-time guidance for cup positioning, leg length restoration, and offset correction.

The system features next-generation accelerometers and gyroscopes, allowing for precise cup positioning across multiple planes, including the functional pelvic plane, anterior pelvic plane, and coronal plane.

It also provides live pelvic tracking, enhancing the accuracy of surgery. Lantern Hip is designed for personalised care, eliminating the need for pre-operative imaging or specialised equipment.

It is compatible with most implant systems, making it particularly suitable for Ambulatory Surgery Centres (ASCs).

The addition of Lantern Hip to OrthAlign’s existing range strengthens the company’s commitment to delivering innovative, cost-effective solutions for joint replacements.

With Lantern Knee and Balance proving successful, this new hip system is expected to improve clinical outcomes and operational efficiency in hip surgeries.

Lantern Hip will be showcased at the upcoming American Association of Hip and Knee Surgeons (AAHKS) annual meeting in Grapevine, Texas, this November. For further information, contact OrthAlign directly at info@orthalign.com.






Source: prnewswire.com

Report Abuse